A patient with advanced head-and-neck cancer regained functional communication using an AI-generated voice clone after total glossectomy and laryngectomy.
Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.